| Symbol |
Name |
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APC
|
adenomatous polyposis coli
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
AXIN1
|
axin 1
|
|
AXIN2
|
axin 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCND1
|
cyclin D1
|
|
CD200
|
CD200 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CST6
|
cystatin E/M
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DHRS3
|
dehydrogenase/reductase (SDR family) member 3
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FOXD3
|
forkhead box D3
|
|
GABPB1
|
GA binding protein transcription factor, beta subunit 1
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFNG
|
interferon, gamma
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IL2
|
interleukin 2
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
KIAA1549
|
KIAA1549
|
|
KIDINS220
|
kinase D-interacting substrate, 220kDa
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF6
|
Kruppel-like factor 6
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT7
|
keratin 7, type II
|
|
KSR1
|
kinase suppressor of ras 1
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK6
|
mitogen-activated protein kinase 6
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MEIS1
|
Meis homeobox 1
|
|
MIR31
|
microRNA 31
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MRAS
|
muscle RAS oncogene homolog
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAQR3
|
progestin and adipoQ receptor family member III
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PHB
|
prohibitin
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PROK1
|
prokineticin 1
|
|
PROM1
|
prominin 1
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RET
|
ret proto-oncogene
|
|
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RIT2
|
Ras-like without CAAX 2
|
|
RND3
|
Rho family GTPase 3
|
|
RNF149
|
ring finger protein 149
|
|
RTN4
|
reticulon 4
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF6
|
serine/arginine-rich splicing factor 6
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
TERT
|
telomerase reverse transcriptase
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
VANGL2
|
VANGL planar cell polarity protein 2
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
